首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1461314

輸液市場：按解決方案、按袋類型、按應用、按最終用戶、按地區、規模、佔有率、前景、機會分析，2024-2031

Intravenous Solutions Market, by Solution, by Bag Type, by Application, by End User, and by Region Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

出版日期: 2024年03月11日 | 出版商:

Coherent Market Insights | 英文 215 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2024 年，全球輸液市場規模將達到 110.4 億美元，預測期內（2024-2031 年）年複合成長率為 6.1%。

報告範圍		報告詳情
基準年	2023年	2023/2024年市場規模	110.4億美元
實際資料	2019-2023	預測期	2024-2031
預測期2023/2024-2030/2031年複合成長率	6.10%	2030/2031 年預測值	166.9億美元

2024 年全球輸液市場規模（十億美元）（按地區）

靜脈輸液是直接給予病人進入靜脈循環的液體。這些輸液是無菌、無熱原的溶液，包裝在單劑量容器中，用於靜脈注射，並用於提供水合作用和熱量。市面上有不同類型的輸液，包括氯化鈉、乳酸林格氏液和葡萄糖水溶液。靜脈治療對於營養缺乏和脫水的患者來說是理想的選擇。脫水會導致多種影響，包括：

體內重要礦物質（電解質）的平衡
認知（心理）能力
能階
胃腸功能（消化食品並產生尿液和糞便的能力）
頭痛的頻率和強度
身體能力
皮膚健康

市場動態

腹瀉病患病率的增加預計將在預測期內推動全球輸液市場的成長。例如，2022年7月，為世界各地兒童提供人道和發展援助的聯合國機構UNICEF（聯合國國際兒童緊急基金）宣布，2019年，全球整體兒童腹瀉佔9%。約有484,000 名兒童死亡。

此外，根據 2018 年 9 月發表在《刺胳針傳染病》上的一篇論文，腹瀉是 2016 年傷殘調整生命年 (DALY) 的第三大原因，佔全球整體7,440 萬 DALY。據同一來源稱，腹瀉是第八大死因，2016 年全球整體1,655,944 人死亡。

本研究的主要特點

本報告以2023年為基準年，對預測期內（2024-2031年）全球輸液市場規模進行了詳細分析。
它揭示了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司簡介、業績、產品系列、地理分佈、分銷策略、關鍵發展和策略等參數，對全球輸液市場的主要企業進行了介紹。
該報告的見解使公司負責人和高階經營團隊能夠就未來產品發布、政府舉措、技術改進、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，如投資者、產品製造商、經銷商、相關人員、研究公司、顧問公司、新參與企業和財務分析師。
相關人員可以透過用於分析全球輸液市場的各種策略矩陣來促進決策。

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東南亞國協
澳洲
韓國
其他亞太地區
中東
波灣合作理事會
以色列
其他中東地區
非洲
北非
中部非洲
南非

第10章競爭格局

熱圖分析
公司簡介
- Baxter International Inc.
- ICU Medical, Inc.
- B. Braun Melsungen Ag
- Grifols, SA
- Fresenius Kabi USA, LLC
- Vifor Pharma Management Ltd.
- JW Life Science
- Amanta Healthcare
- Axa Parenterals Ltd
- Salius Pharma Private Limited.
- Pfizer, Inc.
- Otsuka Pharmaceutical Co., Ltd
- Ajinomoto Co., Inc.
- Braun Melsungen AG
- Soxa Formulations &Research Pvt. Ltd
- Sichuan Kelun Pharmaceutical Co Ltd

第11章分析師建議

繁榮與衰落
綜合機會圖

第12章章節

參考
調查方法

簡介目錄

Product Code: CMI1134

Global intravenous solutions market is estimated to be valued at USD 11.04 Bn in 2024 and is expected to exhibit a CAGR of 6.1% during the forecast period (2024-2031).

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 11.04 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	6.10%	2030/2031 Value Projection:	US$ 16.69 Bn

Global Intravenous Solutions Market Value (US$ Bn), by Region, 2024

Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, non-pyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. Dehydration can contribute to various affects such as

Balance of important minerals (electrolytes) in the body.
Cognitive (mental) performance.
Energy level.
Gastrointestinal function (your ability to digest food and create pee and poop).
Headache frequency and intensity.
Physical performance.
Skin health.

Market Dynamics

Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, in July 2022, UNICEF (United Nations International Children's Emergency Fund), an agency of the United Nations responsible for providing humanitarian and developmental aid to children worldwide, published a report which accounted for 9 per cent of all deaths among children under age 5 worldwide in 2019 due to Diarrhoea, whereas over 1,300 young children dying each day, or about 484,000 children a year globally due to diarrhoea.

Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016 globally.

Key features of the study:

This report provides an in-depth analysis of the global intravenous solutions market, market size (US$ Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2024 - 2031, considering 2023 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global intravenous solutions market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global intravenous solutions market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global intravenous solutions market.

Detailed Segmentation:

Global Intravenous Solutions Market, By Solution type:
- Saline
- Normal Saline (0.9% NaCl)
- Hypertonic Saline
- Dextran
- Lactated Ringer's
- Amino Acid
- Vitamins & Minerals
- Heparin and Trace Elements
- Mixed Solutions
Global Intravenous Solutions Market, By Bag type:
- Large Volume Bags (greater than 250ml)
- Small Volume Bags (less than 250ml)
Global Intravenous Solutions Market, By Application:
- Basic IV Solution
- Nutritional IV Solution
- Blood IV Solution
- Drug IV Solution
- Irrigation IV Solution
Global Intravenous Solutions Market, By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Home Care Settings
Global Intravenous Solutions Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Baxter International Inc.
- ICU Medical, Inc.
- Braun Melsungen Ag
- Grifols, S.A.
- Fresenius Kabi USA, LLC
- Vifor Pharma Management Ltd.
- JW Life Science
- Amanta Healthcare
- Axa Parenterals Ltd.
- Salius Pharma Private Limited.
- Pfizer, Inc.
- Otsuka Pharmaceutical Co., Ltd
- Ajinomoto Co., Inc.
- Braun Melsungen AG
- Soxa Formulations & Research Pvt.Ltd
- Sichuan Kelun Pharmaceutical Co Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Solution
- Market Snapshot, By Bag Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Epidemiology
Porter's Five Forces Analysis

4. Global Intravenous Solutions Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
COVID-19 Impact on the market

5. Global Intravenous Solutions Market, By Solution, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Saline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Normal Saline (0.9% NaCl)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Hypertonic Saline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Dextran
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Lactated Ringer's
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Amino Acid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Vitamins & Minerals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Heparin and trace elements
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Mixed Solutions
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

6. Global Intravenous Solutions Market, By Bag Type, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Large Volume Bags (greater than 250ml)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Small Volume Bags (less than 250ml)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

7. Global Intravenous Solutions Market, By Application, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Basic IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Nutritional IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Blood IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Drug IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Irrigation IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

8. Global Intravenous Solutions Market, By End User, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Ambulatory Surgery Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Home care Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

9. Global Intravenous Solutions Market, By Region, 2019 - 2031, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
North Africa
Central Africa
South Africa

10. Competitive Landscape

Heat Map Analysis
Company Profile
- Baxter International Inc.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- ICU Medical, Inc.
- B. Braun Melsungen Ag
- Grifols, S.A
- Fresenius Kabi USA, LLC
- Vifor Pharma Management Ltd.
- JW Life Science
- Amanta Healthcare
- Axa Parenterals Ltd
- Salius Pharma Private Limited.
- Pfizer, Inc.
- Otsuka Pharmaceutical Co., Ltd
- Ajinomoto Co., Inc.
- Braun Melsungen AG
- Soxa Formulations & Research Pvt. Ltd
- Sichuan Kelun Pharmaceutical Co Ltd